2327.HK Stock Analysis
23
Avoid
Based on Eyestock quantitative analysis, 2327.HK`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Market cap $B
0.104
Dividend yield
22.78 %
Shares outstanding
4 094.55 B
Website
http://www.meilleure.com.cnMeilleure Health International Industry Group Ltd. engages in the research and sale of medicine and health care products, development of chemical and biological products, and multiple industrial investment and holdings. The company employs 123 full-time employees The company went IPO on 2003-10-14. The firm operates its business through five segments. The Trading of Health Care Products, Chemical Materials and Building Materials segment is engaged in the trading of health care products, chemical materials and building materials. The Research and Development segment is engaged in the research and development of chemical and biological products. The Investment and Treasury Function segment is engaged in investment holding and treasury function. The Consultancy and Agency Business segment is engaged in the provision of property agency and consultancy service. The Property Development segment is engaged in the development of residential properties.